RebeccaGBechholdMD

Oncology • Charleston, SC

Breast Cancer, Hematologic Oncology, Hospice & Palliative

Associate Clinical Professor Medical University of South Carolina

Join to view full profile

Dr. Bechhold is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bechhold's full profile

Already have an account?

Office
171 Ashley Ave
Charleston, SC 29425
Phone+1 843-792-1414

Summary

Dr. Rebecca Bechhold is an oncologist in Charleston, SC. She received her medical degree from University of Louisville School of Medicine and has been in practice 39 years. She specializes in breast cancer, hematologic oncology, and hospice & palliative and is experienced in breast cancer, lung cancer, hospice and palliative care.

Education & Training

University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 1981 - 1983
University of Cincinnati1979 - 1981
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1978 - 1981
University of CincinnatiPGY I, 1978 - 1979
University of Louisville School of MedicineClass of 1978

Certifications & Licensure

SC State Medical License 2012 - 2025
FL State Medical License 2005 - 2024
OH State Medical License 1979 - 2017
KY State Medical License 1997 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Career Woman of Achievement YWCA, 2007
Speaking of Women’s Health Honoree 2002
Woman of the Year Cincinnati Enquirer, 1997
Join now to see all

Publications & Presentations

PubMed

43 citations
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response ...
Denise A. Yardley, N. W. Peacock, Mythili Shastry, Howard A. Burris, Rebecca Bechhold
Breast Cancer Research and Treatment. 2015-10-27
3 citations
Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute
Denise A. Yardley, John D. Zubkus, Janice F. Eakle, Rebecca Bechhold, L Finney
Clinical Breast Cancer. 2015-08-01
128 citations
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer
Denise A. Yardley, Robert Weaver, Michelle E. Melisko, Mansoor N. Saleh, Francis P. Arena
Journal of Clinical Oncology. 2015-05-10

Authored Content

Treading Water in the Information TsunamiJuly 2018
Treading Water in the Information TsunamiJuly 2018
Treading Water in the Information TsunamiJuly 2018
Treading Water in the Information TsunamiJuly 2018
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Industry Relationships

Speakers Bureau, Novartis2006 - Present